Skip to main content
OpenTrials
Completed

NCT Number: NCT07017712

Sex Differences in Gastrointestinal Cancer Surgery

This study aims to investigate whether there are differences in surgical outcomes between male and female patients with gastrointestinal cancers (esophagus, colon, rectum, stomach, or pancreas). Previous research suggests that women may have worse outcomes after high-risk surgeries, such as heart or vascular procedures, but it is unclear if this applies to gastrointestinal cancer surgery. The study will analyze population based data from Germany to compare how often male and female patients died or died after the occurence of a surgical complication (failure to rescue) after surgery. The goal is to determine if biological sex influences surgical risks and recovery, which could help improve personalized care for cancer patients.

Completed

Looking for future studies?

Notify Me

Key information

About this study

DATA SOURCE

As database the German diagnosis-related group statistic (DRG statistic) will be queried. The dataset is provided by the German Federal Statistical Office. It includes standardized demographic information (age, sex), diagnostic codes (ICD-10-GM), procedural codes (OPS), and outcomes (mortality, length of stay, complications). Patients will be included if they underwent resection for one of the five specified cancers; exclusions applied for age <18 years, missing sex/age data, or non-matching diagnosis-procedure pairs.

OUTCOMES

Primary Endpoints:

Mortality: Death during the hospital stay. Failure-to-Rescue (FTR): Death among patients who developed postoperative complications (defined via appropriate ICD-10-GM/OPS codes)

Secondary Endpoints: 30-day mortality, complication rates, intensive care unit (ICU) admission, reoperation, and prolonged hospitalization (>75th percentile for procedure-specific stay). Failure to rescue rates of patients with extended medical treatment (eg. after reoperation, ICU admission, possibly in combination with a complication).

Adjustment Variables: Age, Elixhauser comorbidities (categorized using Quan's algorithm), admission type (elective/emergent), annual hospital procedure volume (to account for surgical expertise and routine), and year of surgery (to account for temporal trends).

Descriptive Analysis:

Data Validation: Checks will be performed to identify implausible values (e.g., age >120 years) or inconsistencies (e.g., mortality coded without complication for FTR analysis). Comorbidity Coding: Elixhauser comorbidities will be determined. Hospital Volume Metrics: Annual procedure volumes will be calculated to control for institutional expertise.

Statistical Analysis Plan As primary analysis, multivariable logistic regression models will be calculated that assessed sex differences in mortality/FTR, adjusting for covariates (age, individual Elixhauser comorbidities, hospital volume, and admission type, year of surgery). Adjusted odds ratios (aORs) and adjusted risk differences (aRD) with 95% confidence intervals (CIs) will be reported.

Subgroup / Sensitivity Analyses:

To ensure robustness of results multiple sensitivity analyses will be performed. These include subgroup analysis where tha analysis will be perfomed by startified groups:

  • by admission type (elective vs. emergent),
  • by comorbidity burden (≤3 vs. >4 Elixhauser conditions), and
  • by hospital volume (above/below median).

REPORTING

Descriptive/Univariable analysis:

This study will report descriptively baseline patient characteristics and compare the charachteristics between male and female patients. Tests will be selected according to variable type (categorical vs. continuous) and type of distribution (normal vs non-normal distributed).

Observed outcome rates will be reported and compared between male and female patients. Observed risk differences and risk ratios will be calculated.

Multivariable analysis:

Results of the multivariable logistic regressions will be reported as adjusted risk differences and/or adjusted risk ratios. Appropriate figures will be produced to communicate the results. Sensitivity analyses stratified by admission type, comorbidity burden, and hospital volume will reinforce the robustness of these results.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • at least 18 years old at the time of the operation
  • Rectum resection for carcinoma (ICD-10: C19, C20, C218, D01.1, D01.2) and appropriate resection procedure (5-484, 5-485)
  • Colon resection for carcinoma (ICD-10: C18, D01.0) and appropriate resection procedure (5-455, 5-456, 5-458)
  • Complex esophageal surgery for carcinoma (ICD-10: C15, C16.0) and appropriate resection procedure (5-423, 5-424, 5-425, 5-426, 5-427.0, 5-427.1, 5-438.0, 5-438.1, 5-438.x)
  • Pancreatic resection for carcinoma (ICD-10: C25, C24.1) and appropriate resection procedure (5-524, 5-525.0, 5-525.1, 5-525.2, 5-525.x, 5-525.y, 5-528)
  • Gastric resection for carcinoma (ICD-10: C16) and appropriate resection procedure (5-436, 5-437, 5-438)

Exclusion criteria

  • missing data for age and/or sex
  • implausible combination of diagnosis and resection procedure (eg. a patient with a gastrectomy but without appropriate ICD-10 diagnosis)

Treatment and study plan

Complex esophageal surgery for carcinoma

Procedure

Appropriate combination of ICD-10 code (C15, C16.0) and medical procedure code (5-423, 5-424, 5-425, 5-426, 5-427.0, 5-427.1, 5-438.0, 5-438.1, 5-438.x)

Rectum resection for carcinoma

Procedure

Appropriate combination of ICD-10 code (C19, C20, C218, D011, D012) and medical procedure code (5-484, 5-485)

Colon resection for carcinoma

Procedure

Appropriate combination of ICD-10 code (C18, D01.0) and medical procedure code (5-455, 5-456, 5-458)

Pancreatic resection for carcinoma

Procedure

Appropriate combination of ICD-10 code (C25, C24.1) and medical procedure code (5-524, 5-525.0, 5-525.1, 5-525.2, 5-525.x, 5-525.y, 5-528)

Gastric resection for carcinoma

Procedure

Appropriate combination of ICD-10 code (C16) and medical procedure code (5-436, 5-437, 5-438)

Primary outcomes

  1. Mortality rate

    Time frame: Up to 90 days postoperatively

    Proportion of patients that died after surgical intervention

  2. Failure to rescue

    Time frame: Up to 90 days postoperatively

    Proportion of patients that died after the occurence of a postoperative complication

Secondary outcomes

  1. Complication rate

    Time frame: Up to 90 days postoperatively

    Folloing individual comorbidities are considered:

    Acute myocardial infarction Acute pulmonary embolism Pulmonary insufficiency Sepsis Shock during or resulting from a procedure Shock due to anaesthesia Toxic shock Septic shock Anaphylactic shock Renal failure Haemorrhage Accidental puncture and laceration during a procedure Disruption of operation wound Infection Foreign body accidentally left in body cavity or operation wound following a procedure Acute reaction to foreign substance accidentally left during a procedure Vascular complications following a procedure Other complications of procedures Pancreatoduodenal fistula Peritonitis Anastomotic insufficiency Postoperative bowel occlusion Blood transfusion Other specified complications of surgical and medical care Complication of surgical and medical care, unspecified

  2. Reoperation rate

    Time frame: Up to 90 days postoperatively

    Reoperation during the same hospital stay of the index operation. Identified using the following medical procedure code: 5-983.

  3. Intensive Care Unit admission

    Time frame: Up to 90 days postoperatively

    Postoperative admission to the Intensive Care Unit

  4. Prolonged Lenght of Stay

    Time frame: Up to 90 days postoperatively

    Length of stay above the 75. percentile of all patients with the same diagnosis / procedure combination

  5. Failure to rescue

    Time frame: Up to 90 days postoperatively

    Proportion of patients that died after the occurence of any of the other secondary outcome measures

Sponsors and collaborators

Lead sponsor

Medizinische Hochschule Brandenburg Theodor Fontane

Other

Registry information

Acronym: SeDiGCS

Important dates

Study start
2010
Primary completion
2023
Study completion
2023
First posted
Jun 12, 2025
Registry last updated
Jun 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.